Next Generation Sequencing Market Size, Share & Trends Report

Next Generation Sequencing Market Size, Share & Trends Analysis Report By Technology (Targeted Sequencing & Resequencing), By Product, By Application, By Workflow, By End-use, By Region And Segment Forecasts, 2024 - 2030

  • Report ID: 978-1-68038-428-4
  • Number of Pages: 300
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare

Table of Contents

Chapter 1. Next Generation Sequencing Market: Methodology and Scope
                   1.1. Market Segmentation and Scope
                   1.2. Regional Scope
                   1.3. Estimates and Forecast Timeline
                   1.4. Objective
                   1.5. Research Methodology
                   1.6. Information Procurement
                       1.6.1. Purchased Database
                       1.6.2. GVR’s Internal Database
                       1.6.3. Secondary Sources
                       1.6.4. Primary Research
                   1.7. Information or Data Analysis
                       1.7.1. Data Analysis Models
                   1.8. Market Formulation & Validation
                   1.9. Model Details
                       1.9.1. Commodity Flow Analysis
                   1.10. List of Secondary Sources
                   1.11. List of Abbreviations
Chapter 2. Next Generation Sequencing Market: Executive Summary
                   2.1. Market Snapshot
                   2.2. Segment Snapshot
                   2.3. Competitive Landscape Snapshot
Chapter 3. Next Generation Sequencing Market: Variables, Trends & Scope
                   3.1. Market Segmentation and Scope
                   3.2. Market Lineage Outlook
                       3.2.1. Parent Market Outlook
                       3.2.2. Related/Ancillary Market Outlook
                   3.3. Market Trends and Outlook
                   3.4. Market Dynamics
                       3.4.1. Exponentially decreasing costs for genetic sequencing
                       3.4.2. Development of companion diagnostics and personalized medicine
                       3.4.3. Rise in competition among prominent market entities
                       3.4.4. Rising clinical opportunity for NGS technology
                       3.4.5. Technological advancements in cloud computing and data integration
                       3.4.6. Growing healthcare expenditure supporting development of effective diagnostic & therapeutic procedures for cancer
                       3.4.7. Increasing prevalence of cancer
                   3.5. Market Restraint Analysis
                       3.5.1. Lack of computational efficiency for data management
                       3.5.2. Non–value-based NGS reimbursement policy and regulation status
                       3.5.3. Challenges associated with NGS implementation.
                   3.6. Market Analysis Tools
                       3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
                       3.6.2. Porter’s Five Forces Analysis
                       3.6.3. COVID-19 Impact Analysis
Chapter 4. Technology Business Analysis
                   4.1. Next Generation Sequencing Data Analysis Market: Technology Movement Analysis
                   4.2. Targeted sequencing & resequencing
                       4.2.1. Targeted Sequencing & Resequencing Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       4.2.2. DNA-based targeted sequencing & resequencing
                           4.2.2.1. DNA-based targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
                       4.2.3. RNA-based targeted sequencing & resequencing
                           4.2.3.1. RNA -based targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
                   4.3. Whole genome sequencing
                       4.3.1. Whole Genome Sequencing Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   4.4. Whole exome sequencing
                       4.4.1. Whole Exome Sequencing Market Estimates and Forecast, 2018 - 2030 (USD Million)
Chapter 5. Product Business Analysis
                   5.1. Next Generation Sequencing Data Analysis Market: Product Movement Analysis
                   5.2. Platforms
                       5.2.1. Platforms Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       5.2.2. Sequencing
                           5.2.2.1. Sequencing Platforms Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       5.2.3. Data Analysis
                           5.2.3.1. Data Analysis Platforms Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   5.3. Consumables
                       5.3.1. Consumables Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       5.3.2. Sample Preparation
                           5.3.2.1. Sample Preparation Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       5.3.3. Target Enrichment
                           5.3.3.1. Target Enrichment Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       5.3.4. Others
                           5.3.4.1. Others Market Estimates and Forecast, 2018 - 2030 (USD Million)
Chapter 6. Application Business Analysis
                   6.1. Next Generation Sequencing Data Analysis Market: Application Movement Analysis
                   6.2. Oncology
                       6.2.1. Oncology Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       6.2.2. Diagnostics & Screening
                           6.2.2.1. Diagnostics & Screening Market Estimates And Forecast, 2018 - 2030 (USD Million)
                           6.2.2.2. Oncology screening
                               6.2.2.2.1. Oncology Screening Market Estimates and Forecast, 2018 - 2030 (USD Million)
                               6.2.2.2.2. Sporadic Cancer Screening Market Estimates and Forecast, 2018 - 2030 (USD Million)
                               6.2.2.2.3. Inherited Cancer Screening Market Estimates and Forecast, 2018 - 2030 (USD Million)
                           6.2.2.3. Companion diagnostics
                               6.2.2.3.1. Companion Diagnostics Market Estimates and Forecast, 2018 - 2030 (USD Million)
                           6.2.2.4. Other Diagnostics
                               6.2.2.4.1. Other Diagnostics Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       6.2.3. Research Studies
                           6.2.3.1. Research Studies Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   6.3. Clinical Investigation
                       6.3.1. Clinical Investigation Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       6.3.2. Infectious Diseases
                           6.3.2.1. Infectious Diseases Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       6.3.3. Idiopathic Diseases
                           6.3.3.1. Idiopathic Diseases Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       6.3.4. Inherited Diseases
                           6.3.4.1. Inherited Diseases Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       6.3.5. Non-communicable/other Diseases
                           6.3.5.1. Reproductive Health Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   6.4. Reproductive Health
                       6.4.1. Clinical Investigation Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       6.4.2. NIPT
                           6.4.2.1. NIPT Market Estimates and Forecast, 2018 - 2030 (USD Million)
                           6.4.2.2. Aneuploidy
                               6.4.2.2.1. Aneuploidy Market Estimates and Forecast, 2018 - 2030 (USD Million)
                           6.4.2.3. Microdeletions
                               6.4.2.3.1. Microdeletions Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       6.4.3. PGT
                           6.4.3.1. PGT Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       6.4.4. Newborn Genetic Screening
                           6.4.4.1. Newborn Genetic Screening Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       6.4.5. Single Gene Analysis Market
                           6.4.5.1. Single Gene Analysis Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   6.5. HLA Typing/Immune System Monitoring
                       6.5.1. HLA Typing/Immune System Monitoring Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   6.6. Metagenomics, Epidemiology & Drug Development
                       6.6.1. Metagenomics, Epidemiology & Drug Development Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   6.7. Agrigenomics & Forensics
                       6.7.1. Agrigenomics & Forensics Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   6.8. Consumer Genomics
                       6.8.1. Consumer Genomics Market Estimates and Forecast, 2018 - 2030 (USD Million)
Chapter 7. Workflow Business Analysis
                   7.1. Next Generation Sequencing Data Analysis Market: Workflow Movement Analysis
                   7.2. Presequencing
                       7.2.1. Presequencing Market Estimates and Forecast, 2018 - 2030 (USD Million)
                           7.2.1.1. NGS Library Preparation Kits
                               7.2.1.1.1. NGS Library Preparation Kits Market Estimates and Forecast, 2018 - 2030 (USD Million)
                           7.2.1.2. Semiautomated Library Preparation
                               7.2.1.2.1. Semiautomated Library Preparation Market Estimates and Forecast, 2018 - 2030 (USD Million)
                           7.2.1.3. Automated Library Preparation
                               7.2.1.3.1. Automated Library Preparation Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   7.3. Sequencing
                       7.3.1. Sequencing Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   7.4. Data Analysis
                       7.4.1. Data Analysis Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       7.4.2. Primary Data Analysis Market Estimates and Forecast, 2018 - 2030 (USD Million)
                           7.4.2.1. Primary Data Analysis Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       7.4.3. Secondary Data Analysis Market Estimates and Forecast, 2018 - 2030 (USD Million)
                           7.4.3.1. Secondary Data Analysis Market Estimates and Forecast, 2018 - 2030 (USD Million)
                       7.4.4. Tertiary Data Analysis Market Estimates and Forecast, 2018 - 2030 (USD Million)
                           7.4.4.1. Tertiary Data Analysis Market Estimates and Forecast, 2018 - 2030 (USD Million)
Chapter 8. End - Use Business Analysis
                   8.1. Next Generation Sequencing Market: End - Use Movement Analysis
                   8.2. Academic Research
                       8.2.1. Academic Research Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   8.3. Clinical Research
                       8.3.1. Clinical Research Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   8.4. Hospitals & Clinics
                       8.4.1. Hospitals & Clinics Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   8.5. Pharmaceutical & Biotech Entities
                       8.5.1. Pharmaceutical & Biotech Entities Market Estimates and Forecast, 2018 - 2030 (USD Million)
                   8.6. Other Users
                       8.6.1. Other Users Market Estimates and Forecast, 2018 - 2030 (USD Million)
Chapter 9. Regional Business Analysis
                   9.1. Next Generation Sequencing Market Share By Region, 2022 & 2030
                   9.2. North America
                       9.2.1. SWOT Analysis
                       9.2.2. North America next generation sequencing market, 2018 - 2030 (USD Million)
                       9.2.3. U.S.
                           9.2.3.1. Key country dynamics
                           9.2.3.2. U.S. next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.2.3.3. Target disease prevalence
                           9.2.3.4. Competitive scenario
                           9.2.3.5. Regulatory framework
                           9.2.3.6. Reimbursement scenario
                       9.2.4. Canada
                           9.2.4.1. Key country dynamics
                           9.2.4.2. Canada next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.2.4.3. Target disease prevalence
                           9.2.4.4. Competitive scenario
                           9.2.4.5. Regulatory framework
                           9.2.4.6. Reimbursement scenario
                       9.2.5. Europe
                       9.2.6. SWOT Analysis
                       9.2.7. Europe Next Generation Sequencing market, 2018 - 2030 (USD Million)
                       9.2.8. Germany
                           9.2.8.1. Key country dynamics
                           9.2.8.2. Germany next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.2.8.3. Target disease prevalence
                           9.2.8.4. Competitive scenario
                           9.2.8.5. Regulatory framework
                           9.2.8.6. Reimbursement scenario
                       9.2.9. UK
                           9.2.9.1. Key country dynamics
                           9.2.9.2. UK next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.2.9.3. Target disease prevalence
                           9.2.9.4. Competitive scenario
                           9.2.9.5. Regulatory framework
                           9.2.9.6. Reimbursement scenario
                       9.2.10. France
                           9.2.10.1. Key country dynamics
                           9.2.10.2. France next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.2.10.3. Target disease prevalence
                           9.2.10.4. Competitive scenario
                           9.2.10.5. Regulatory framework
                           9.2.10.6. Reimbursement scenario
                       9.2.11. Italy
                           9.2.11.1. Key country dynamics
                           9.2.11.2. Italy next generation sequencing (NGS) market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.2.11.3. Target disease prevalence
                           9.2.11.4. Competitive scenario
                           9.2.11.5. Regulatory framework
                           9.2.11.6. Reimbursement scenario
                       9.2.12. Spain
                           9.2.12.1. Key country dynamics
                           9.2.12.2. Spain next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.2.12.3. Target disease prevalence
                           9.2.12.4. Competitive scenario
                           9.2.12.5. Regulatory framework
                           9.2.12.6. Reimbursement scenario
                       9.2.13. Denmark
                           9.2.13.1. Key country dynamics
                           9.2.13.2. Denmark next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.2.13.3. Target disease prevalence
                           9.2.13.4. Competitive scenario
                           9.2.13.5. Regulatory framework
                           9.2.13.6. Reimbursement scenario
                       9.2.14. Sweden
                           9.2.14.1. Key country dynamics
                           9.2.14.2. Sweden next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.2.14.3. Target disease prevalence
                           9.2.14.4. Competitive scenario
                           9.2.14.5. Regulatory framework
                           9.2.14.6. Reimbursement scenario
                       9.2.15. Norway
                           9.2.15.1. Key country dynamics
                           9.2.15.2. Norway next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.2.15.3. Target disease prevalence
                           9.2.15.4. Competitive scenario
                           9.2.15.5. Regulatory framework
                           9.2.15.6. Reimbursement scenario
                   9.3. Asia Pacific
                       9.3.1. SWOT Analysis
                       9.3.2. Asia Pacific next generation sequencing market, 2018 - 2030 (USD Million)
                       9.3.3. Japan
                           9.3.3.1. Key country dynamics
                           9.3.3.2. Japan next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.3.3.3. Target disease prevalence
                           9.3.3.4. Competitive scenario
                           9.3.3.5. Regulatory framework
                           9.3.3.6. Reimbursement scenario
                       9.3.4. China
                           9.3.4.1. Key country dynamics
                           9.3.4.2. China next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.3.4.3. Target disease prevalence
                           9.3.4.4. Competitive scenario
                           9.3.4.5. Regulatory framework
                           9.3.4.6. Reimbursement scenario
                       9.3.5. India
                           9.3.5.1. Key country dynamics
                           9.3.5.2. India next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.3.5.3. Target disease prevalence
                           9.3.5.4. Competitive scenario
                           9.3.5.5. Regulatory framework
                           9.3.5.6. Reimbursement scenario
                       9.3.6. South Korea
                           9.3.6.1. Key country dynamics
                           9.3.6.2. South Korea next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.3.6.3. Target disease prevalence
                           9.3.6.4. Competitive scenario
                           9.3.6.5. Regulatory framework
                           9.3.6.6. Reimbursement scenario
                       9.3.7. Australia
                           9.3.7.1. Key country dynamics
                           9.3.7.2. Australia next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.3.7.3. Target disease prevalence
                           9.3.7.4. Competitive scenario
                           9.3.7.5. Regulatory framework
                           9.3.7.6. Reimbursement scenario
                       9.3.8. Thailand
                           9.3.8.1. Key country dynamics
                           9.3.8.2. Thailand next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.3.8.3. Target disease prevalence
                           9.3.8.4. Competitive scenario
                           9.3.8.5. Regulatory framework
                           9.3.8.6. Reimbursement scenario
                   9.4. Latin America
                       9.4.1. SWOT Analysis
                       9.4.2. Latin America next generation sequencing market, 2018 - 2030 (USD Million)
                       9.4.3. Brazil
                           9.4.3.1. Key country dynamics
                           9.4.3.2. Brazil next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.4.3.3. Target disease prevalence
                           9.4.3.4. Competitive scenario
                           9.4.3.5. Regulatory framework
                           9.4.3.6. Reimbursement scenario
                       9.4.4. Mexico
                           9.4.4.1. Key country dynamics
                           9.4.4.2. Mexico next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.4.4.3. Target disease prevalence
                           9.4.4.4. Competitive scenario
                           9.4.4.5. Regulatory framework
                           9.4.4.6. Reimbursement scenario
                       9.4.5. Argentina
                           9.4.5.1. Key country dynamics
                           9.4.5.2. Argentina next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.4.5.3. Target disease prevalence
                           9.4.5.4. Competitive scenario
                           9.4.5.5. Regulatory framework
                           9.4.5.6. Reimbursement scenario
                   9.5. MEA
                       9.5.1. SWOT Analysis
                       9.5.2. MEA next generation sequencing market, 2018 - 2030 (USD Million)
                       9.5.3. South Africa
                           9.5.3.1. Key country dynamics
                           9.5.3.2. South Africa next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.5.3.3. Target disease prevalence
                           9.5.3.4. Competitive scenario
                           9.5.3.5. Regulatory framework
                           9.5.3.6. Reimbursement scenario
                       9.5.4. Saudi Arabia
                           9.5.4.1. Key country dynamics
                           9.5.4.2. Saudi Arabia next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.5.4.3. Target disease prevalence
                           9.5.4.4. Competitive scenario
                           9.5.4.5. Regulatory framework
                           9.5.4.6. Reimbursement scenario
                       9.5.5. UAE
                           9.5.5.1. Key country dynamics
                           9.5.5.2. UAE next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.5.5.3. Target disease prevalence
                           9.5.5.4. Competitive scenario
                           9.5.5.5. Regulatory framework
                           9.5.5.6. Reimbursement scenario
                       9.5.6. Kuwait
                           9.5.6.1. Key country dynamics
                           9.5.6.2. Kuwait next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
                           9.5.6.3. Target disease prevalence
                           9.5.6.4. Competitive scenario
                           9.5.6.5. Regulatory framework
                           9.5.6.6. Reimbursement scenario
Chapter 10. Competitive Landscape
                   10.1. Participant’s Overview
                   10.2. Company Categorization
                   10.3. Financial Performance
                   10.4. Product Benchmarking
                   10.5. Company Market Share Analysis
                   10.6. Strategy Mapping
                       10.6.1. THERMO FISHER SCIENTIFIC, INC.
                           10.6.1.1. Overview
                           10.6.1.2. Life Technologies Corporation
                               10.6.1.2.1. Overview
                           10.6.1.3. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.1.4. Product Benchmarking
                           10.6.1.5. Strategic Initiatives
                       10.6.2. QIAGEN N.V
                           10.6.2.1. Overview
                           10.6.2.2. CLC Bio
                               10.6.2.2.1. Overview
                           10.6.2.3. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.2.4. Product Benchmarking
                           10.6.2.5. Strategic Initiatives
                       10.6.3. Illumina, Inc.
                           10.6.3.1. Overview
                           10.6.3.2. Edico Genome
                               10.6.3.2.1. Overview
                           10.6.3.3. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.3.4. Product Benchmarking
                           10.6.3.5. Strategic Initiatives
                       10.6.4. F. Hoffmann-La Roche Ltd
                           10.6.4.1. Overview
                           10.6.4.2. Foundation Medicine
                               10.6.4.2.1. Overview
                           10.6.4.3. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.4.4. Product Benchmarking
                           10.6.4.5. Strategic Initiatives
                       10.6.5. Agilent Technologies, Inc.
                           10.6.5.1. Overview
                           10.6.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.5.3. Product Benchmarking
                           10.6.5.4. Strategic Initiatives
                       10.6.6. Bio-Rad Laboratories, Inc.
                           10.6.6.1. Overview
                           10.6.6.2. GnuBio
                               10.6.6.2.1. Overview
                           10.6.6.3. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.6.4. Product Benchmarking
                           10.6.6.5. Strategic Initiatives
                       10.6.7. PierianDx
                           10.6.7.1. Overview
                           10.6.7.2. Tute Genomics
                           10.6.7.2.1. GnuBio
                               10.6.7.2.2. Knome, Inc
                                   10.7.7.2.2.1 COMPANY OVERVIEW
                           10.6.7.3. Product Benchmarking
                           10.6.7.4. Strategic Initiatives
                       10.6.8. Oxford Nanopore Technologies Plc
                           10.6.8.1. Overview
                           10.6.8.2. Product Benchmarking
                           10.6.8.3. Strategic Initiatives
                       10.6.9. Partek Incorporated
                           10.6.9.1. Overview
                           10.6.9.2. Product Benchmarking
                           10.6.9.3. Strategic Initiatives
                       10.6.10. Eurofins Scientific
                           10.6.10.1. Overview
                           10.6.10.2. Eurofins GATC Biotech GmbH
                               10.6.10.2.1. Overview
                           10.6.10.3.
                           10.6.10.4. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.10.5. Product Benchmarking
                           10.6.10.6. Strategic Initiatives
                       10.6.11. DNASTAR, Inc.
                           10.6.11.1. Overview
                           10.6.11.2. Product Benchmarking
                           10.6.11.3. Strategic Initiatives
                       10.6.12. SOPHIA GENETICS
                           10.6.12.1. Overview
                           10.6.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.12.3. Product Benchmarking
                           10.6.12.4. Strategic Initiatives
                       10.6.13. Fabric Genomics, Inc.
                           10.6.13.1. Overview
                           10.6.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.13.3. Product Benchmarking
                           10.6.13.4. Strategic Initiatives
                       10.6.14. Laboratory Corporation of America
                           10.6.14.1. Overview
                           10.6.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.14.3. Product Benchmarking
                           10.6.14.4. Strategic Initiatives
                       10.6.15. SYAPSE, INC.
                           10.6.15.1. Overview
                           10.6.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.15.3. Product Benchmarking
                           10.6.15.4. Strategic Initiatives
                           10.6.16. IQVIA
                           10.6.16.1. Overview
                           10.6.16.2. Q² Solutions
                           10.6.16.2.1. Overview
                           10.6.16.3. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.16.4. Product Benchmarking
                           10.6.16.5. Strategic Initiatives
                       10.6.17. Personalis, Inc
                           10.6.17.1. Overview
                           10.6.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.17.3. Product Benchmarking
                           10.6.17.4. Strategic Initiatives
                       10.6.18. 10x Genomics
                           10.6.18.1. Overview
                           10.6.18.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.18.3. Product Benchmarking
                           10.6.18.4. Strategic Initiatives
                       10.6.19. DNAnexus, Inc
                           10.6.19.1. Overview
                           10.6.19.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.19.3. Product Benchmarking
                           10.6.19.4. Strategic Initiatives
                       10.6.20. CENTOGENE N.V
                           10.6.20.1. Overview
                           10.6.20.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.20.3. Product Benchmarking
                           10.6.20.4. Strategic Initiatives
                       10.6.21. Invitae Corporation
                           10.6.21.1. Overview
                           10.6.21.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.21.3. Product Benchmarking
                           10.6.21.4. Strategic Initiatives
                       10.6.22. GeneDx, LLC
                           10.6.22.1. Overview
                           10.6.22.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           10.6.22.3. Product Benchmarking
                           10.6.22.4. Strategic Initiatives


List of Tables

Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Country share estimation
Table 4. Healthcare expenditure, 2022
Table 5. NGS top platforms
Table 6. Base pairs sequenced using WGS, WES, and targeted sequencing & resequencing
Table 7. Clonal amplification products in the market
Table 8. North America next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 9. North America next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 10. North America next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 11. North America next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 12. North America NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 13. North America NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 14. North America next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 15. North America next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 16. North America targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 17. North America next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 18. North America NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 19. North America NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 20. North America next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 21. U.S. next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 22. U.S. next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 23. U.S. next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 24. U.S. next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 25. U.S. NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 26. U.S. NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 27. U.S. next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 28. U.S. next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 29. U.S. targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 30. U.S. next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 31. U.S. NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 32. U.S. NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 33. U.S. next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 34. Canada next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 35. Canada next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 36. Canada next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 37. Canada next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 38. Canada NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 39. Canada NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 40. Canada next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 41. Canada next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 42. Canada targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 43. Canada next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 44. Canada NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 45. Canada NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 46. Canada next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 47. Europe next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 48. Europe next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 49. Europe next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 50. Europe next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 51. Europe NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 52. Europe NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 53. Europe next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 54. Europe next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 55. Europe targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 56. Europe next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 57. Europe NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 58. Europe NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 59. Europe next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 60. Germany next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 61. Germany next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 62. Germany next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 63. Germany next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 64. Germany NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 65. Germany NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 66. Germany next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 67. Germany next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 68. Germany targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 69. Germany next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 70. Germany NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 71. Germany NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 72. Germany next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 73. U.K. next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 74. U.K. next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 75. U.K. next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 76. U.K. next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 77. U.K. NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 78. U.K. NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 79. U.K. next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 80. U.K. next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 81. U.K. targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 82. U.K. next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 83. U.K. NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 84. U.K. NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 85. U.K. next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 86. Spain next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 87. Spain next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 88. Spain next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 89. Spain next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 90. Spain NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 91. Spain NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 92. Spain next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 93. Spain next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 94. Spain targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 95. Spain next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 96. Spain NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 97. Spain NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 98. Spain next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 99. France next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 100. France next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 101. France next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 102. France next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 103. France NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 104. France NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 105. France next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 106. France next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 107. France targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 108. France next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 109. France NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 110. France NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 111. France next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 112. Italy next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 113. Italy next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 114. Italy next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 115. Italy next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 116. Italy NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 117. Italy NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 118. Italy next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 119. Italy next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 120. Italy targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 121. Italy next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 122. Italy NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 123. Italy NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 124. Italy next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 125. Italy next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 126. Denmark next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 127. Denmark next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 128. Denmark next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 129. Denmark next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 130. Denmark NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 131. Denmark NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 132. Denmark next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 133. Denmark next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 134. Denmark targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 135. Denmark next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 136. Denmark NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 137. Denmark NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 138. Denmark next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 139. Norway next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 140. Norway next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 141. Norway next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 142. Norway next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 143. Norway NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 144. Norway NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 145. Norway next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 146. Norway next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 147. Norway targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 148. Norway next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 149. Norway NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 150. Norway NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 151. Norway next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 152. Sweden next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 153. Sweden next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 154. Sweden next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 155. Sweden next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 156. Sweden NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 157. Sweden NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 158. Sweden next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 159. Sweden next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 160. Sweden targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 161. Sweden next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 162. Sweden NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 163. Sweden NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 164. Sweden next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 165. Asia Pacific next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 166. Asia Pacific next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 167. Asia Pacific next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 168. Asia Pacific next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 169. Asia Pacific NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 170. Asia Pacific NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 171. Asia Pacific next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 172. Asia Pacific next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 173. Asia Pacific targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 174. Asia Pacific next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 175. Asia Pacific NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 176. Asia Pacific NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 177. Asia Pacific next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 178. Japan next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 179. Japan next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 180. Japan next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 181. Japan next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 182. Japan NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 183. Japan NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 184. Japan next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 185. Japan next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 186. Japan targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 187. Japan next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 188. Japan NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 189. Japan NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 190. Japan next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 191. China next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 192. China next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 193. China next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 194. China next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 195. China NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 196. China NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 197. China next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 198. China next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 199. China targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 200. China next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 201. China NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 202. China NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 203. China next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 204. India next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 205. India next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 206. India next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 207. India next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 208. India NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 209. India NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 210. India next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 211. India next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 212. India targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 213. India next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 214. India NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 215. India NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 216. India next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 217. South Korea next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 218. South Korea next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 219. South Korea next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 220. South Korea next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 221. South Korea NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 222. South Korea NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 223. South Korea next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 224. South Korea next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 225. South Korea targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 226. South Korea next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 227. South Korea NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 228. South Korea NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 229. South Korea next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 230. Australia next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 231. Australia next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 232. Australia next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 233. Australia next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 234. Australia NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 235. Australia NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 236. Australia next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 237. Australia next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 238. Australia targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 239. Australia next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 240. Australia NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 241. Australia NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 242. Australia next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 243. Thailand next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 244. Thailand next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 245. Thailand next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 246. Thailand next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 247. Thailand NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 248. Thailand NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 249. Thailand next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 250. Thailand next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 251. Thailand targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 252. Thailand next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 253. Thailand NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 254. Thailand NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 255. Thailand next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 256. Latin America next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 257. Latin America next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 258. Latin America next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 259. Latin America next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 260. Latin America NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 261. Latin America NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 262. Latin America next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 263. Latin America next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 264. Latin America targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 265. Latin America next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 266. Latin America NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 267. Latin America NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 268. Latin America next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 269. Brazil next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 270. Brazil next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 271. Brazil next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 272. Brazil next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 273. Brazil NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 274. Brazil NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 275. Brazil next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 276. Brazil next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 277. Brazil targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 278. Brazil next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 279. Brazil NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 280. Brazil NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 281. Brazil next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 282. Mexico next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 283. Mexico next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 284. Mexico next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 285. Mexico next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 286. Mexico NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 287. Mexico NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 288. Mexico next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 289. Mexico next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 290. Mexico targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 291. Mexico next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 292. Mexico NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 293. Mexico NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 294. Mexico next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 295. Argentina next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 296. Argentina next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 297. Argentina next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 298. Argentina next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 299. Argentina NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 300. Argentina NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 301. Argentina next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 302. Argentina next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 303. Argentina targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 304. Argentina next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 305. Argentina NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 306. Argentina NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 307. Argentina next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 308. MEA next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 309. MEA next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 310. MEA next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 311. MEA next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 312. MEA NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 313. MEA NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 314. MEA next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 315. MEA next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 316. MEA targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 317. MEA next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 318. MEA NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 319. MEA NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 320. MEA next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 321. South Africa next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 322. South Africa next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 323. South Africa next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 324. South Africa next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 325. South Africa NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 326. South Africa NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 327. South Africa next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 328. South Africa next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 329. South Africa targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 330. South Africa next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 331. South Africa NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 332. South Africa NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 333. South Africa next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 334. Saudi Arabia next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 335. Saudi Arabia next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 336. Saudi Arabia next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 337. Saudi Arabia next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 338. Saudi Arabia NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 339. Saudi Arabia NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 340. Saudi Arabia next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 341. Saudi Arabia next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 342. Saudi Arabia targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 343. Saudi Arabia next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 344. Saudi Arabia NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 345. Saudi Arabia NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 346. Saudi Arabia next generation sequencing market estimates & forecasts, by end--use, 2018 - 2030 (USD Million)
Table 347. UAE next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 348. UAE next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 349. UAE next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 350. UAE next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 351. UAE NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 352. UAE NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 353. UAE next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 354. UAE next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 355. UAE targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 356. UAE next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 357. UAE NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 358. UAE NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 359. UAE next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
Table 360. Kuwait next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 361. Kuwait next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 362. Kuwait next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
Table 363. Kuwait next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
Table 364. Kuwait NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 365. Kuwait NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
Table 366. Kuwait next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
Table 367. Kuwait next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 368. Kuwait targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
Table 369. Kuwait next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 370. Kuwait NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 371. Kuwait NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
Table 372. Kuwait next generation sequencing market estimates & forecasts, by end--use, 2018 - 2030 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Next Generation Sequencing, Market Segmentation
Fig. 8 Market Snapshot, 2022
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2022
Fig. 16 Global Next Generation Sequencing Market: Product Movement Analysis
Fig. 17 Global Next Generation Sequencing Market, for Platforms, 2018 - 2030 (USD Million)
Fig. 18 Global Next Generation Sequencing Market, for Sequencing, 2018 - 2030 (USD Million)
Fig. 19 Global Next Generation Sequencing Market, for Data Analysis, 2018 - 2030 (USD Million)
Fig. 20 Global Next Generation Sequencing Market, for Consumables, 2018 - 2030 (USD Million)
Fig. 21 Global Next Generation Sequencing Market, for Sample Preparation, 2018 - 2030 (USD Million)
Fig. 22 Global Next Generation Sequencing Market, for Target Enrichment, 2018 - 2030 (USD Million)
Fig. 23 Global Next Generation Sequencing Market: Application, Movement Analysis
Fig. 24 Global Next Generation Sequencing Market, for Oncology, 2018 - 2030 (USD Million)
Fig. 25 Global Next Generation Sequencing Market, for Diagnostics & Screening, 2018 - 2030 (USD Million)
Fig. 26 Global Next Generation Sequencing Market, for Screening, 2018 - 2030 (USD Million)
Fig. 27 Global Next Generation Sequencing Market, for Sporadic Cancer, 2018 - 2030 (USD Million)
Fig. 28 Global Next Generation Sequencing Market, for Inherited Cancer, 2018 - 2030 (USD Million)
Fig. 29 Global Next Generation Sequencing Market, for Companion Diagnostics, 2018 - 2030 (USD Million)
Fig. 30 Global Next Generation Sequencing Market, for Other Diagnostics, 2018 - 2030 (USD Million)
Fig. 31 Global Next Generation Sequencing Market, for Research Studies, 2018 - 2030 (USD Million)
Fig. 32 Global Next Generation Sequencing Market, for Clinical Investigation, 2018 - 2030 (USD Million)
Fig. 33 Global Next Generation Sequencing Market for Infectious Diseases 2018 - 2030 (USD Million)
Fig. 34 Global Next Generation Sequencing Market, for Idiopathic Diseases, 2018 - 2030 (USD Million)
Fig. 35 Global Next Generation Sequencing Market, for Inherited Diseases, 2018 - 2030 (USD Million)
Fig. 36 Global Next Generation Sequencing Market, for Non-Communicable/Other Diseases, 2018 - 2030 (USD Million)
Fig. 37 Global Next Generation Sequencing Market, for Reproductive Health, 2018 - 2030 (USD Million)
Fig. 38 Global Next Generation Sequencing Market, for NIPT, 2018 - 2030 (USD Million)
Fig. 39 Global Next Generation Sequencing Market for Aneuploidy, 2018 - 2030 (USD Million)
Fig. 40 Global Next Generation Sequencing Market, for Microdeletions, 2018 - 2030 (USD Million)
Fig. 41 Global Next Generation Sequencing Market, for PGT, 2018 - 2030 (USD Million)
Fig. 42 Global Next Generation Sequencing Market for Newborn Genetic Screening, 2018 - 2030 (USD Million)
Fig. 43 Global Next Generation Sequencing Market, for Single Gene Analysis, 2018 - 2030 (USD Million)
Fig. 44 Global Next Generation Sequencing Market, for HLA Typing/Immune System Monitoring, 2018 - 2030 (USD Million)
Fig. 45 Global Next Generation Sequencing Market, for Metagenomics, Epidemiology & Drug Development, 2018 - 2030 (USD Million)
Fig. 46 Global Next Generation Sequencing Market for Agrigenomics & Forensics, 2018 - 2030 (USD Million)
Fig. 47 Global Next Generation Sequencing Market, for Consumer Genomics, 2018 - 2030 (USD Million)
Fig. 48 Global Next Generation Sequencing Market: Technology Movement Analysis
Fig. 49 Global Next Generation Sequencing Market for Whole Genome Sequencing, 2018 - 2030 (USD Million)
Fig. 50 Global Next Generation Sequencing Market, for Whole Exome Sequencing, 2018 - 2030 (USD Million)
Fig. 51 Global Next Generation Sequencing Market, for Targeted Sequencing & Resequencing, 2018 - 2030 (USD Million)
Fig. 52 Global Next Generation Sequencing Market, for DNA-based, 2018 - 2030 (USD Million)
Fig. 53 Global Next Generation Sequencing Market for RNA-based, 2018 - 2030 (USD Million)
Fig. 54 Global Next Generation Sequencing Market: Workflow Movement Analysis
Fig. 55 Global Next Generation Sequencing Market, for Pre-Sequencing, 2018 - 2030 (USD Million)
Fig. 56 Global Next Generation Sequencing Market, for Library Preparation, 2018 - 2030 (USD Million)
Fig. 57 Global Next Generation Sequencing Market for NGS Library Preparation Kits, 2018 - 2030 (USD Million)
Fig. 58 Global Next Generation Sequencing Market for Semi-automated Library Preparation, 2018 - 2030 (USD Million)
Fig. 59 Global Next Generation Sequencing Market for Automated Library Prepartion, 2018 - 2030 (USD Million)
Fig. 60 Global Next Generation Sequencing Market for Others, 2018 - 2030 (USD Million)
Fig. 61 Global Next Generation Sequencing Market for Sequencing, 2018 - 2030 (USD Million)
Fig. 62 Global Next Generation Sequencing Market for NGS Data Analysis, 2018 - 2030 (USD Million)
Fig. 63 Global Next Generation Sequencing Market for NGS Primary Data Analysis, 2018 - 2030 (USD Million)
Fig. 64 Global Next Generation Sequencing Market for NGS Secondary Data Analysis, 2018 - 2030 (USD Million)
Fig. 65 Global Next Generation Sequencing Market for NGS Tertiary Data Analysis, 2018 - 2030 (USD Million)
Fig. 66 Global Next Generation Sequencing Market: End-use Movement Analysis
Fig. 67 Global Next Generation Sequencing Market for Academic Research, 2018 - 2030 (USD Million)
Fig. 68 Global Next Generation Sequencing Market for Clinical Research, 2018 - 2030 (USD Million)
Fig. 69 Global Next Generation Sequencing Market for Hospitals & Clinics, 2018 - 2030 (USD Million)
Fig. 70 Global Next Generation Sequencing Market for Pharma & Biotech Entities, 2018 - 2030 (USD Million)
Fig. 71 Global Next Generation Sequencing Market for Other users, 2018 - 2030 (USD Million)
Fig. 72 Regional Marketplace: Key Takeaways Other users
Fig. 73 Regional Outlook, 2022 & 2030
Fig. 74 Global Next Generation Sequencing Market: Region Movement Analysis
Fig. 75 North America Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 76 U.S. Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 77 Canada Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 78 Europe Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 79 Germany Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 80 UK Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 81 France Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 82 Italy Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 83 Spain Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 84 Denmark Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 85 Sweden Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 86 Norway Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 87 Asia Pacific Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 88 Japan Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 89 China Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 90 India Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 91 South Korea Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 92 Australia Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 93 Thailand Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 94 Latin America Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 95 Brazil Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 96 Mexico Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 97 Argentina Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 98 Middle East and Africa Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 99 South Africa Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 100 Saudi Arabia Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 101 UAE Next Generation Sequencing Market, 2018 - 2030 (USD Million)
Fig. 102 Kuwait Next Generation Sequencing Market, 2018 - 2030 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon